Based on the prognostic signature, we screened a great deal of potential prognostic biomarkers and successfully validated NEUROD1 as a novel prognostic biomarker in PaCa. This evidence concerns the gene NEUROD1 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.